Belgium/epidemiology; Humans; Lung Neoplasms/epidemiology; Belgium; Lung Neoplasms; Oncology; Pulmonary and Respiratory Medicine
Disciplines :
Oncology
Author, co-author :
Ocak, Sebahat; Division of Pneumology, CHU UCL Namur (Godinne Site), Université catholique de Louvain (UCLouvain), Yvoir, Belgium, Pole of Pneumology, ENT, and Dermatology (PNEU), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium. Electronic address: sebahat.ocak@uclouvain.be
Tournoy, Kurt; Division of Pneumology, Onze-Lieve-Vrouw Ziekenhuis (OLV) Aalst and Faculty of Medicine and Life Sciences, Ghent University, Ghent, Belgium
Demedts, Ingel; Division of Pneumology, AZ Delta Roeselare, Roeselare, Belgium
Durieux, Rodolphe ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chirurgie cardio-vasculaire et thoracique
Janssens, Annelies; Division of Thoracic Oncology, UZ Antwerpen, Edegem, Belgium
Moretti, Luigi; Department of Radiation Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Nackaerts, Kristiaan; Division of Respiratory Oncology/Pneumology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
Pieters, Thierry; Cliniques Universitaires St-Luc, UCLouvain, Brussels, Belgium, Pole of Pneumology, ENT, and Dermatology (PNEU), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium
Surmont, Veerle; Division of Pneumology, UZ Gent, Ghent, Belgium
Van Eycken, Liesbet; Belgian Cancer Registry (BCR), Brussels, Belgium
Vrijens, France; Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium
Weynand, Birgit; Department of Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
van Meerbeeck, Jan P; Division of Thoracic Oncology, UZ Antwerpen, Edegem, Belgium
The authors thank Leon D'hulster and Pieter Van Meenen (National Institute for Health and Disability) for providing recent figures on endoscopic procedures.
Gerkens, S., Farfan-Portet, M.-I., Desomer, A., et al. Het Belgisch Gezondheidssysteem in 2010. Health Services Research, Federaal Kenniscentrum voor de Gezondheidszorg (KCE). Accessed May 16, 2021 https://kce.fgov.be/sites/default/files/atoms/files/KCE_138A_het_Belgische_gezondheidssysteem_second_print.pdf.
OCED. Stat. Health expenditure and financing. https://stats.oecd.org/Index.aspx?DataSetCode=SHA. (Accessed 16 May 2021)
Service public fédéral, Sante Publique, Securite de la Chaine Alimentaire Et Environment. Colophon. https://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/donnees_phares_soins_de_sante_hg_v07.pdf. (Accessed 16 May 2021)
federale overheidsdienst. The Cancer plan. https://www.health.belgium.be/nl/het-kankerplan. (Accessed 16 May 2021)
zorgkwaliteit. Kwaliteitsindicatoren voor long- en rectumkanker in Vlaamse ziekenhuizen. https://zorgkwaliteit.be/sites/default/files/imports/20210505_Persbericht_IndicatorenOncologie.pdf. (Accessed 16 May 2021)
OECD. Stat. Health care resources: medical technology. https://stats.oecd.org/Index.aspx?QueryId=30184#. (Accessed 16 May 2021)
Luengo-Fernandez, R., Leal, J., Gray, A., Sullivan, R., Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 14 (2013), 1165–1174.
Neyt, M., Devos, C., Thiry, N., et al. Benefits and costs of innovative oncology drugs in Belgium (2004-2017). Health Technology Assessment (HTA) Brussels: Belgian Health Care Knowledge Centre (KCE). Accessed May 16, 2021 https://kce.fgov.be/sites/default/files/atoms/files/KCE_343_Innovative_oncology_drugs_in_Belgium_Report.pdf.
Belgian Cancer Registry. Publications. http://kankerregister.org/Publications. (Accessed 1 June 2021)
ECIS—European Cancer Information System. https://ecis.jrc.ec.europa.eu. (Accessed 1 June 2021)
Van Walle, L., Tambuyzer, T., Silversmit, G., et al. Cancer incidence in Belgium, 2004–2017. Belgr J Oncol 15 (2021), 4–10.
Belgian Cancer Registry. Cancer in an ageing population in Belgium 2004–2016. Accessed May 16, 2021 https://kankerregister.org/media/docs/SKR_publicatie2018_CancerinanAgeingPopulation(landscape)5_12_2018.pdf.
Wauters, I., Robays, J., Verleye, L., et al. Non-small cell and small cell lung cancer: diagnosis, treatment and follow-up. KCE Reports. https://kce.fgov.be/sites/default/files/page_documents/KCE_206_lung_cancer.pdf. (Accessed 16 May 2021)
The Economist Intelligence Unit Healthcare. Breathing in a new era: a comparative analysis of lung cancer policies across Europe. http://www.eiu.com/graphics/marketing/pdf/Lung-Cancer%20in-Europe-EIU-2019-9-10-final.pdf. (Accessed 16 May 2021)
Vrijens, F., De Gendt, C., Verleye, L., et al. Quality of care and variability in lung cancer management across Belgian hospitals: a population-based study using routinely available data. Int J Qual Health Care 30 (2018), 306–312.
Vrijens, F., Verleye, L., De Gendt, C., et al. Quality indicators for the management of lung cancer. Brussels. KCE Reports. http://kce.fgov.be/sites/default/files/page_documents/KCE_266_LungCancer_Report.pdf. (Accessed 16 May 2021)
Verleye, L., De Gendt, C., Vrijens, F., et al. Patterns of care for non-small cell lung cancer patients in Belgium: a population-based study. Eur J Cancer Care (Engl), 27, 2018 10.111/ecc.12747.
Schillemans, V., Vrijens, F., De Gendt, C., et al. Association between surgical volume and post-operative mortality and survival after surgical resection in lung cancer in Belgium: a population-based study. Eur J Surg Oncol 45 (2019), 2443–2450.
Sciensano. HIS2018—Health survey 2018. https://www.sciensano.be/nl/projecten/gezondheidsenquete-2018. (Accessed 24 May 2021)
European Commission. Public health. https://ec.europa.eu/health/eurobarometers_en. (Accessed 24 May 2021)
VRGT. https://rookstop.vrgt.be/. (Accessed 24 May 2021)
Joossens, L., Feliu, A., Fernandez, E., The tobacco control scale 2019 in Europe. Association of European Cancer Leagues, Catalan Institute of Oncology. http://www.tobaccocontrolscale.org/TCS2019.pdf. (Accessed 24 May 2021)
Agentschap Zorg & Gezondheid. Population survey. https://www.zorg-en-gezondheid.be/bevolkingsonderzoek. (Accessed 24 May 2021)
Game Changers IPSOS. Rookenquete 2020. https://www.kanker.be/sites/default/files/rapport_2020.pdf. (Accessed 24 May 2021)
Dooms, C., Weynand, B., Vander Borght, S., et al. Molecular diagnostics on tissue samples obtained through EBUS-TBNA: review on practice guidelines. Belgr J Oncol 10 (2016), 15–20.
Thunnissen, E., Weynand, B., Udovicic-Gagula, D., et al. Lung cancer biomarker testing: perspective from Europe. Transl Lung Cancer Res 9 (2020), 887–897.
Hébrant, A., Lammens, M., Van den Broecke, C., et al. Algorithms for molecular testing in solid tumours. Belgr J Oncol 13 (2019), 286–295.
ComPerMed. https://www.compermed.be/en. (Accessed 15 May 2021)
Pauwels, P., Remmelink, M., Hoton, D., et al. Pathological diagnosis and molecular testing in non-small cell lung cancer: Belgian guidelines. Belgr J Oncol 10 (2016), 123–131.
Pauwels, P., Remmelink, M., Hoton, D., et al. PD-L1 testing for non-small cell lung cancer: Belgian guidelines. Belgr J Oncol 12 (2018), 233–238.
De Winne, K., Sorber, L., Lambin, S., et al. Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial. Virchows Arch 478 (2021), 283–291.
Keppens, C., Tack, V., Hart, N., et al. A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer. Oncotarget 9 (2018), 20524–20538.
Institute of Epidemiology and Hygiene. Laboratory quality service. https://www.wiv-isp.be/QML/index_nl.htm. (Accessed 16 May 2021)
ESMO. ESMO clinical practice guidelines: lung and chest tumours. https://www.esmo.org/guidelines/lung-and-chest-tumours. (Accessed 16 May 2021)
Rami-Porta, R., Call, S., Dooms, C., et al. Lung cancer staging: a concise update. Eur Respir J, 51, 2018, 1800190.
Annema, J.T., van Meerbeeck, J.P., Rintoul, R.C., et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA 304 (2010), 2245–2252.
Rintoul, R.C., Glover, M.J., Jackson, C., et al. Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: a health economics analysis of the ASTER trial from a European perspective. Thorax 69 (2014), 679–681.
Crombag, L.M.M., Dooms, C., Stigt, J.A., et al. Systematic and combined endosonographic staging of lung cancer (SCORE study). Eur Respir J, 53, 2019, 1800800.
Coosemans, W., Lerut, T.E., Van Raemdonck, D.E., Thoracoscopic surgery: the Belgian experience. Ann Thorac Surg 56 (1993), 721–730.
European Society of Thoracic Surgeons. Database reports. https://www.ests.org/ests_database/database_reports.aspx. (Accessed 16 May 2021)
Maiga, A.W., Deppen, S.A., Pinkerman, R., et al. Timeliness of care and lung cancer tumor-stage progression: how long can we wait?. Ann Thorac Surg 104 (2017), 1791–1797.
Stokstad, T., Sørhaug, S., Amundsen, T., Grønberg, B.H., Medical complexity and time to lung cancer treatment - a three-year retrospective chart review. BMC Health Serv Res, 17, 2017, 45.
Labbé, C., Anderson, M., Simard, S., et al. Wait times for diagnosis and treatment of lung cancer: a single-centre experience. Curr Oncol 24 (2017), 367–373.
Ng, C., Maier, H., Augustin, F., Lung cancer screening—the surgeon's perspective. Memo Mag Eur Med Oncol 12 (2019), 171–174.
OECD. Radiotherapy equipment. https://data.oecd.org/healtheqt/radiotherapy-equipment.htm#indicator-chart. (Accessed 30 June 2021)
Cotteels, C., Peeters, D., Coucke, P.A., Thomas, I., [Location of radiotherapy centers: an exploratory geographic analysis for Belgium]. Cancer Radiother 16 (2012), 604–612.
Lievens, Y., Defourny, N., Coffey, M., et al. Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol 112 (2014), 178–186.
Lievens, Y., De Schutter, H., Stellamans, K., Rosskamp, M., Van Eycken, L., Belgian College for Physicians in Radiation Oncology. Radiotherapy access in Belgium: how far are we from evidence-based utilisation?. Eur J Cancer 84 (2017), 102–113.
ClinicalTrials.gov. ProCaLung: Project on cancer of the lung (ProCaLung). https://clinicaltrials.gov/ct2/show/NCT04726358. (Accessed 31 May 2021)
Global Legal Insights. Pricing & reimbursement laws and regulations 2021 Belgium. https://www.globallegalinsights.com/practice-areas/pricing-and-reimbursement-laws-and-regulations/belgium. (Accessed 14 May 2021)
European Federation of Pharmaceutical Industries and Associations. EFPIA patients W.A.I.T. indicator 2019 survey. https://www.efpia.eu/publications/downloads/efpia/efpia-patients-wait-indicator-2019-survey/. (Accessed 9 June 2021)
EURACAN. https://euracan.eu/. (Accessed 21 June 2021)
Dingemans, A.C., Früh, M., Ardizzoni, A., et al. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(☆). Ann Oncol 32 (2021), 839–853.
Planchard, D., Popat, S., Kerr, K., et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29 (2018), iv192–iv237.
Baudin, E., Caplin, M., Garcia-Carbonero, R., et al. Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(☆). Ann Oncol 32 (2021), 439–451.
Pentheroudakis, G., ESMO Guidelines Committee. Recent eUpdate to the ESMO Clinical Practice Guidelines on early and locally advanced non-small-cell lung cancer (NSCLC). Ann Oncol 31 (2020), 1265–1266.
Hanna, N.H., Robinson, A.G., Temin, S., et al. Therapy for stage IV non–small-cell lung cancer with driver alterations: ASCO and OH (CCO) joint guideline update. J Clin Oncol 39 (2021), 1040–1091.
Hanna, N.H., Schneider, B.J., Temin, S., et al. Therapy for stage IV non–small-cell lung cancer without driver alterations: ASCO and OH (CCO) joint guideline update. J Clin Oncol 38 (2020), 1608–1632.
KCE. https://kce.fgov.be/. (Accessed 9 June 2021)
Bernheim, J.L., Distelmans, W., Mullie, A., Ashby, M.A., Questions and answers on the Belgian model of integral end-of-life care: experiment? Prototype?: “Eu-euthanasia”: the close historical, and evidently synergistic, relationship between palliative care and euthanasia in Belgium: an interview with a doctor involved in the early development of both and two of his successors. J Bioeth Inq 11 (2014), 507–529.
Pardon, K., Deschepper, R., Vander Stichele, R., et al. Expressed wishes and incidence of euthanasia in advanced lung cancer patients. Eur Respir J 40 (2012), 949–956.
Vanbutsele, G., Deliens, L., Cocquyt, V., Cohen, J., Pardon, K., Chambaere, K., Use and timing of referral to specialized palliative care services for people with cancer: a mortality follow-back study among treating physicians in Belgium. PLoS One, 14, 2019, e0210056.
Janssens, A., Teugels, L., Kohl, S., Michielsen, T., Leysen, B., van Meerbeeck, J.P., Practical tools for implementing early palliative care in advanced lung cancer. Eur Respir J 47 (2016), 1010–1012.
